Hippocampal Neurons Exhibit Cyclothiazide-Sensitive Rapidly Desensitizing Responses to Kainate

Total Page:16

File Type:pdf, Size:1020Kb

Hippocampal Neurons Exhibit Cyclothiazide-Sensitive Rapidly Desensitizing Responses to Kainate The Journal of Neuroscience, August 1993, 13(E): 34983509 Hippocampal Neurons Exhibit Cyclothiazide-sensitive Rapidly Desensitizing Responses to Kainate Doris K. Patneau,’ Ladislav Vyklicky, Jr.,* and Mark L. Mayer’ ‘Laboratory of Cellular and Molecular Neurophysiology, NICHD, NIH, Bethesda, Maryland 20892 and *Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, The Czech Republic In whole-cell recordings from mammalian CNS neurons, Glutamate receptors in the rat CNS are known to be formed AMPA-preferring glutamate receptors exhibit strong desen- from several gene families (Sommer and Seeburg, 1992). Ex- sitization in response to AMPA, glutamate, and quisqualate, periments on receptors generatedusing in vitro expression sys- but not to kainate or domoate. Such desensitization is re- tems provide evidence for AMPA-preferring subtypes assem- duced by lectins, by the nootropic drug aniracetam, and by bled from combinations of glutamate receptor subunits GluRl- diazoxide. None of these compounds strongly modulate re- GluR4 (Boulter et al., 1990) also referred to asGluR-A through sponses to kainate and domoate, consistent with the ap- GluR-D (Keinanen et al., 1990) and kainate-preferring subtypes parent lack of desensitization to these agonists. We now assembledfrom GluRS-GluR7 (Bettler et al., 1990, 1992; Ege- report experiments on hippocampal neurons in which re- bjerg et al., 1991) most likely in combination with IL41 and sponses to kainate were strongly potentiated by cyclothia- KA2 (Werner et al., 1991; Herb et al., 1992). At AMPA-pre- zide, a benzothiadiazine diuretic and antihypertensive drug ferring glutamate receptors, kainate acts with low potency and structurally related to diazoxide. Cyclothiazide increased the produces nondesensitizing responseswhile AMPA and gluta- maximum response to a saturating concentration of kainate mate produce rapidly and strongly desensitizing responses by approximately 300% and produced a shift to the left in (Sommer et al., 1990). In contrast, kainate is a potent agonist the kainate dose-response curve. Because cyclothiazide at kainate-preferring glutamate receptors and producesstrongly was considerably more effective than aniracetam in reducing desensitizing responseswhile AMPA is inactive or of very low desensitization evoked by glutamate, we tested the possi- potency (Egebjerg et al., 1991; Herb et al., 1992). Numerous bility that potentiation of responses to kainate was due to studieshave reported nondesensitizingresponses to kainate and block of a previously undetected component of desensiti- domoate and rapidly desensitizing responsesto AMPA, gluta- zation in the response to kainate itself. In outside-out patch- mate, and quisqualatein hippocampal neurons, consistent with es responses to rapid perfusion of 3 mu kainate showed the expressionof AMPA-preferring glutamate receptors (e.g., 34% desensitization, the onset of which developed with a Kiskin et al., 1986; Trussell et al., 1988; Mayer and Vyklicky, time constant of 2.2 msec. Desensitization of responses to 1989; Patneau and Mayer, 1990, 1991; Jonas and Sakmann, kainate was abolished by 100 I.IM cyclothiazide, as was the 1992). Compared to their action on hippocampal neurons, kai- much stronger desensitization evoked by glutamate and nate and domoate are more potent agonistsat dorsal root gan- AMPA. Cyclothiazide also slowed the rate of deactivation of glion (DRG) neurons and produce strongly desensitizing re- responses to kainate recorded after return to agonist-free sponses,consistent with the expression of kainate-preferring solution. Current-voltage plots for control responses to kai- receptorsin sensoryneurons (Huettner, 1990; Wong et al., 1992). nate exhibited outward rectification that was associated with The different functional responseof hippocampal neurons to a reduction in the amount of desensitization on depolariza- AMPA and kainate raisesthe question as to why someagonists tion. Both effects were absent in the presence of cyclothia- produce desensitization at AMPA-preferring receptors while zide, suggesting that rectification of responses to kainate others apparently do not. Previously we characterized the ac- was due to the voltage dependence of desensitization. The tions of a series of willardiines on hippocampal neurons and complete block of desensitization produced by cyclothia- proposed that agonist-dependentdifferences in relative affinity zide provides a powerful new tool for analysis of allosteric for the active and desensitizedstates of AMPA-preferring gluta- regulatory mechanisms at AMPA-preferring glutamate re- mate receptors could account for variation in the degree of ceptors. desensitization evoked by different agonists (Patneau et al., [Keywords: kainate, AMPA, desensitization, hippocam- 1992a). According to this hypothesis, kainate binds to the de- pus, excitatory amino acids, cyclothiazide, glutamate re- sensitizedstate(s) of AMPA-preferring glutamate receptorswith ceptor, allosteric regulation, concentration jumpj much lower affinity than doesAMPA, glutamate, or quisqualate (Patneau and Mayer, 1991; Mayer et al., 1992). Our hypothesis raised two issues.First, kainate might indeed produce desen- Received Nov. 25, 1992; revised Feb. 3, 1993; accepted Feb. 24, 1993. sitization at AMPA-preferring glutamate receptors,but lesspro- We thank Christine Winters for preparation of cell cultures, Drs. C. E. Jahr and G. L. Westbrook for advice on constructing the piezoelectric element perfusion found than occurs with AMPA or glutamate, and too rapid to system, Dr. M. J. Benveniste for reading the manuscript, and Drs. K. Yamada measurewith whole-cell recording. Second, substancesthat re- and S. Rothman for sharing results prior to publication. duce desensitization at AMPA receptors should potentiate re- Correspondence should be addressed to Dr. M. L. Mayer, Building 49, Room 5A78, National Institutes of Health, Bethesda, MD 20892. sponsesto kainate. The lectins and drugs that have been tested Copyright 0 1993 Society for Neuroscience 0270-6474/93/133496-14$05.00/O previously for activity at AMPA-preferring glutamate receptors The Journal of Neuroscience, August 1993, f3(8) 3497 have relatively weak effects on desensitization. Although ani- aniracetam, from Hoffman-La Roche (Nutley, NJ). Cyclothiazide and racetam (5 mM) produces nearly lo-fold potentiation of equi- aniracetam were dissolved in dimethyl sulfoxide (DMSO) at 20 and 500 mM, respectively, before dilution with extracellular solution, In several librium responses to glutamate, substantial (84%) desensitiza- experiments the control solution also contained 0.5% DMSO (the con- tion still occurs in the presence of 5 mM aniracetam (Vyklicky centration present in extracellular recording solution containing 100 PM et al., 199 1). The relief of desensitization at AMPA-preferring cyclothiazide). Salts, biochemicals, and excitatory amino acids were glutamate receptors by the lectins concanavalin A and WGA is purchased from Aldrich, Diagnostic Chemicals, Molecular Probes, Sig- even less than produced by aniracetam (Mayer and Vyklicky, ma, and Tocris Neuramin. Analysis. In many cases agonist-evoked currents exhibited significant 1989; Vyklicky et al., 199 l), and suggests that these substances rundown, particularly in outside-out patches; this was time dependent fail to affect responses to kainate because their effect on desen- rather than activity dependent, and apparently unaffected by cyclothia- sitization is weak. zide, suggesting that rundown is not due to a cyclothiazide-sensitive, The recent discovery that diazoxide and some structurally absorbing desensitized state. The rundown was much slower in whole- cell recording, in nucleated macropatches, and in nystatin vesicles. related derivatives are considerably more efficacious than ani- Whenever possible control responses recorded before and after an ex- racetam in reducing desensitization at AMPA-preferring gluta- perimental manipulation were used to correct for rundown. In com- mate receptors (Yamada and Rothman, 199 1, 1992; Yamada, parisons between agonists (e.g., kainate and glutamate) applications were 1992) offered the possibility to reexamine whether desensiti- alternated and several sequential responses averaged. Because the wash- zation is evoked by kainate. We report here experiments that out of cyclothiazide was so slow, analysis of the degree of potentiation by cyclothiazide was performed by comparing control responses im- show that kainate produces substantial, but very rapid, desen- mediately preceding the application of cyclothiazide with the first few sitization at AMPA-preferring glutamate receptors in hippo- potentiated responses. Decay time constants and rates of onset of de- campal neurons, and that such desensitization is completely sensitization were fit with one or the sum of two exponentials using blocked by cyclothiazide, a benzothiadiazine related in structure PCLAMP (Axon Instruments). Dose+response curves were fit to the equa- to diazoxide (Yamada, 1992). tion I = I,,, x (l/(1 + (EC,,/[ligand])‘)), (1) Materials and Methods where I-, is the response at a saturating concentration of ligand; EC,,, Cell culture and recording techniques. Newborn SpragucDawley rats the concentration of ligand producing a half-maximal response; [ligand], were killed by decapitation, and the hippocampi dissected. Neurons the concentration of ligand, and n, the Hill coefficient. Data are given were plated on a confluent glial cell feeder layer as previously described
Recommended publications
  • Characterization of a Domoic Acid Binding Site from Pacific Razor Clam
    Aquatic Toxicology 69 (2004) 125–132 Characterization of a domoic acid binding site from Pacific razor clam Vera L. Trainer∗, Brian D. Bill NOAA Fisheries, Northwest Fisheries Science Center, Marine Biotoxin Program, 2725 Montlake Blvd. E., Seattle, WA 98112, USA Received 5 November 2003; received in revised form 27 April 2004; accepted 27 April 2004 Abstract The Pacific razor clam, Siliqua patula, is known to retain domoic acid, a water-soluble glutamate receptor agonist produced by diatoms of the genus Pseudo-nitzschia. The mechanism by which razor clams tolerate high levels of the toxin, domoic acid, in their tissues while still retaining normal nerve function is unknown. In our study, a domoic acid binding site was solubilized from razor clam siphon using a combination of Triton X-100 and digitonin. In a Scatchard analysis using [3H]kainic acid, the partially-purified membrane showed two distinct receptor sites, a high affinity, low capacity site with a KD (mean ± S.E.) of 28 ± 9.4 nM and a maximal binding capacity of 12 ± 3.8 pmol/mg protein and a low affinity, high capacity site with a mM affinity for radiolabeled kainic acid, the latter site which was lost upon solubilization. Competition experiments showed that the rank order potency for competitive ligands in displacing [3H]kainate binding from the membrane-bound receptors was quisqualate > ibotenate > iodowillardiine = AMPA = fluorowillardiine > domoate > kainate > l-glutamate. At high micromolar concentrations, NBQX, NMDA and ATPA showed little or no ability to displace [3H]kainate. In contrast, Scatchard analysis 3 using [ H]glutamate showed linearity, indicating the presence of a single binding site with a KD and Bmax of 500 ± 50 nM and 14 ± 0.8 pmol/mg protein, respectively.
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • A Human Stem Cell-Derived Test System for Agents Modifying Neuronal N
    Archives of Toxicology (2021) 95:1703–1722 https://doi.org/10.1007/s00204-021-03024-0 IN VITRO SYSTEMS A human stem cell‑derived test system for agents modifying neuronal 2+ N‑methyl‑D‑aspartate‑type glutamate receptor Ca ‑signalling Stefanie Klima1,2 · Markus Brüll1 · Anna‑Sophie Spreng1,3 · Ilinca Suciu1,3 · Tjalda Falt1 · Jens C. Schwamborn4 · Tanja Waldmann1 · Christiaan Karreman1 · Marcel Leist1,5 Received: 28 October 2020 / Accepted: 4 March 2021 / Published online: 13 March 2021 © The Author(s) 2021 Abstract Methods to assess neuronal receptor functions are needed in toxicology and for drug development. Human-based test systems that allow studies on glutamate signalling are still scarce. To address this issue, we developed and characterized pluripotent stem cell (PSC)-based neural cultures capable of forming a functional network. Starting from a stably proliferating neu- roepithelial stem cell (NESC) population, we generate “mixed cortical cultures” (MCC) within 24 days. Characterization by immunocytochemistry, gene expression profling and functional tests (multi-electrode arrays) showed that MCC contain various functional neurotransmitter receptors, and in particular, the N-methyl-D-aspartate subtype of ionotropic glutamate receptors (NMDA-R). As this important receptor is found neither on conventional neural cell lines nor on most stem cell- derived neurons, we focused here on the characterization of rapid glutamate-triggered Ca2+ signalling. Changes of the intra- 2+ cellular free calcium ion concentration ([Ca ]i) were measured by fuorescent imaging as the main endpoint, and a method to evaluate and quantify signals in hundreds of cells at the same time was developed. We observed responses to glutamate in the low µM range.
    [Show full text]
  • L-Proline and Glutamatergic Neurotransmission: Clarifying The
    L-Proline and Glutamatergic Neurotransmission: Clarifying the Modulatory Role of Neuronal L-Proline Transporter Dissertation zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Daniel Schulz aus Troisdorf Bonn 06.12.2011 Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn 1. Gutachter: Prof. Dr. Eva Kostenis 2. Gutachter: Prof. Dr. Klaus Mohr Tag der Promotion: 26.03.12 Erscheinungsjahr: 2012 Die vorliegende Arbeit wurde in der Zeit von April 2007 bis November 2011 am Institut für Pharmazeutische Biologie der Rheinischen Friedrich-Wilhelms Universität Bonn unter der Leitung von Frau Prof. Dr. rer. nat. Evi Kostenis durchgeführt. Abstract I Abstract The neuronal high affinity L-proline transporter (PROT) is a putative neurotransmitter transporter whose contribution to neurotransmission is still unknown. PROT is expressed exclusively in brain by subpopulations of glutamatergic neurons and is assumed to conduct the reuptake of L-proline, which is released upon depolarization. Since to date no specific high-affinity receptor for L-proline has been discovered, the amino acid has been suggested to play a role regulating glutamatergic neurotransmission. To uncover the in vivo modulatory function of PROT, a mouse strain lacking functional PROT was generated and confirmed. The analysis of these PROT-knockout mice provided new insights into the modulatory functional roles of this transporter. Biochemical alterations within the central nervous system of PROT lacking mice were identified. Thus, PROT-deficient mice exhibit increased expression levels of N-methyl-D-aspartic acid (NMDA), α-amino-3-hydroxy-5 methylisoxazolepropionic acid (AMPA) and kainate (KA) receptor subunits.
    [Show full text]
  • Agmatine Reverses Pain Induced by Inflammation, Neuropathy, and Spinal Cord Injury
    Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury Carolyn A. Fairbanks*†, Kristin L. Schreiber†, Kori L. Brewer‡, Chen-Guang Yu§, Laura S. Stone†, Kelley F. Kitto*†, H. Oanh Nguyen*, Brent M. Grocholski*, Don W. Shoeman*, Lois J. Kehl¶, Soundararajan Regunathanʈ, Donald J. Reisʈ, Robert P. Yezierski§, and George L. Wilcox*†** Departments of *Pharmacology and †Neuroscience and ¶Oral Science, University of Minnesota, Minneapolis, MN 55455; §University of Miami, The Miami Project, Miami, FL 33136; ʈDepartment of Neurology and Neuroscience, Weill–Cornell University Medical College, New York, NY 10021; and ‡East Carolina University School of Medicine, Department of Emergency Medicine, Greenville, NC 27858 Edited by Susan E. Leeman, Boston University School of Medicine, Boston, MA, and approved July 11, 2000 (received for review November 17, 1999) Antagonists of glutamate receptors of the N-methyl-D-aspartate geenan (CARRA), ketamine, dextromethorphan, ifenprodil, ␻ subclass (NMDAR) or inhibitors of nitric oxide synthase (NOS) aminoguanidine, N -nitro-L-arginine methyl ester (L-NAME), AG, prevent nervous system plasticity. Inflammatory and neuropathic NMDA, substance P (SP), memantine, and ␣-amino-3-hydroxy-5- pain rely on plasticity, presenting a clinical opportunity for the use methyl-4-isoxazolepropionic acid (AMPA)͞metabotropic agonist of NMDAR antagonists and NOS inhibitors in chronic pain. Agma- quisqualate (QUIS; Sigma); dynorphin (DYN; National Institute tine (AG), an endogenous neuromodulator present in brain and on Drug Abuse), SK&F 86466 (SmithKline Beecham), efaxoran spinal cord, has both NMDAR antagonist and NOS inhibitor activ- (Research Biochemicals), and moxonidine (Solvay Pharma). SP ities. We report here that AG, exogenously administered to ro- and moxonidine were dissolved in acidified saline; CARRA was dents, decreased hyperalgesia accompanying inflammation, nor- dissolved in PBS; and all the other drugs were dissolved in 0.9% malized the mechanical hypersensitivity (allodynia͞hyperalgesia) normal saline.
    [Show full text]
  • Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors
    Neurochemical Research (2019) 44:735–750 https://doi.org/10.1007/s11064-018-02712-1 REVIEW PAPER Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors Sumit Barua1 · Jong Youl Kim1 · Jae Young Kim1 · Jae Hwan Kim4 · Jong Eun Lee1,2,3 Received: 15 October 2018 / Revised: 19 December 2018 / Accepted: 24 December 2018 / Published online: 4 January 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract The central nervous system (CNS) is the most injury-prone part of the mammalian body. Any acute or chronic, central or peripheral neurological disorder is related to abnormal biochemical and electrical signals in the brain cells. As a result, ion channels and receptors that are abundant in the nervous system and control the electrical and biochemical environment of the CNS play a vital role in neurological disease. The N-methyl-D-aspartate receptor, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid receptor, kainate receptor, acetylcholine receptor, serotonin receptor, α2-adrenoreceptor, and acid-sensing ion channels are among the major channels and receptors known to be key components of pathophysiological events in the CNS. The primary amine agmatine, a neuromodulator synthesized in the brain by decarboxylation of L-arginine, can regu- late ion channel cascades and receptors that are related to the major CNS disorders. In our previous studies, we established that agmatine was related to the regulation of cell differentiation, nitric oxide synthesis, and murine brain endothelial cell migration, relief of chronic pain, cerebral edema, and apoptotic cell death in experimental CNS disorders.
    [Show full text]
  • DIURETICS Diuretics Are Drugs That Promote the Output of Urine Excreted by the Kidneys
    DIURETICS Diuretics are drugs that promote the output of urine excreted by the Kidneys. The primary action of most diuretics is the direct inhibition of Na+ transport at one or more of the four major anatomical sites along the nephron, where Na+ reabsorption takes place. The increased excretion of water and electrolytes by the kidneys is dependent on three different processes viz., glomerular filtration, tubular reabsorption (active and passive) and tubular secretion. Diuretics are very effective in the treatment of Cardiac oedema, specifically the one related with congestive heart failure. They are employed extensively in various types of disorders, for example, nephritic syndrome, diabetes insipidus, nutritional oedema, cirrhosis of the liver, hypertension, oedema of pregnancy and also to lower intraocular and cerebrospinal fluid pressure. Therapeutic Uses of Diuretics i) Congestive Heart Failure: The choice of the diuretic would depend on the severity of the disorder. In an emergency like acute pulmonary oedema, intravenous Furosemide or Sodium ethacrynate may be given. In less severe cases. Hydrochlorothiazide or Chlorthalidone may be used. Potassium-sparing diuretics like Spironolactone or Triamterene may be added to thiazide therapy. ii) Essential hypertension: The thiazides usually sever as primary antihypertensive agents. They may be used as sole agents in patients with mild hypertension or combined with other antihypertensives in more severe cases. iii) Hepatic cirrhosis: Potassium-sparing diuretics like Spironolactone may be employed. If Spironolactone alone fails, then a thiazide diuretic can be added cautiously. Furosemide or Ethacrymnic acid may have to be used if the oedema is regractory, together with spironolactone to lessen potassium loss. Serum potassium levels should be monitored periodically.
    [Show full text]
  • A Review of Glutamate Receptors I: Current Understanding of Their Biology
    J Toxicol Pathol 2008; 21: 25–51 Review A Review of Glutamate Receptors I: Current Understanding of Their Biology Colin G. Rousseaux1 1Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada Abstract: Seventy years ago it was discovered that glutamate is abundant in the brain and that it plays a central role in brain metabolism. However, it took the scientific community a long time to realize that glutamate also acts as a neurotransmitter. Glutamate is an amino acid and brain tissue contains as much as 5 – 15 mM glutamate per kg depending on the region, which is more than of any other amino acid. The main motivation for the ongoing research on glutamate is due to the role of glutamate in the signal transduction in the nervous systems of apparently all complex living organisms, including man. Glutamate is considered to be the major mediator of excitatory signals in the mammalian central nervous system and is involved in most aspects of normal brain function including cognition, memory and learning. In this review, the basic biology of the excitatory amino acids glutamate, glutamate receptors, GABA, and glycine will first be explored. In the second part of this review, the known pathophysiology and pathology will be described. (J Toxicol Pathol 2008; 21: 25–51) Key words: glutamate, glycine, GABA, glutamate receptors, ionotropic, metabotropic, NMDA, AMPA, review Introduction and Overview glycine), peptides (vasopressin, somatostatin, neurotensin, etc.), and monoamines (norepinephrine, dopamine and In the first decades of the 20th century, research into the serotonin) plus acetylcholine. chemical mediation of the “autonomous” (autonomic) Glutamatergic synaptic transmission in the mammalian nervous system (ANS) was an area that received much central nervous system (CNS) was slowly established over a research activity.
    [Show full text]
  • Subpallial Origin of a Population of Projecting Pioneer Neurons During Corticogenesis
    Subpallial origin of a population of projecting pioneer neurons during corticogenesis Javier Morante-Oria*†‡, Alan Carleton*‡, Barbara Ortino†§, Eric J. Kremer¶, Alfonso Faire´ n†ʈ, and Pierre-Marie Lledo*ʈ** *Laboratory of Perception and Memory, Centre National de la Recherche Scientifique, Unite´de Recherche Associe´e 2182, Pasteur Institute, 25 Rue du Docteur Roux, 75724 Paris, France; †Instituto de Neurociencias, Consejo Superior de Investigaciones Cientı´ficas,Universidad Miguel Herna´ndez, 03550 San Juan de Alicante, Spain; §Dipartimento Neurofisiologia Sperimentale, Istituto ‘‘C. Besta’’, Via Celoria 11, 20133 Milan, Italy; and ¶Centre National de la Recherche Scientifique, Unite´Mixte de Recherche 5535, 1919 Route du Monde, 34293 Montpellier, France Communicated by D. Carleton Gajdusek, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France, June 16, 2003 (received for review February 17, 2003) Pyramidal neurons of the mammalian cerebral cortex are gener- reliable markers of such neurons. We show that MZ pioneer ated in the ventricular zone of the pallium whereas the subpallium neurons migrate tangentially to the MZ from subpallial sources. provides the cortex with inhibitory interneurons. The marginal We demonstrate that such a migration is reelin-dependent and, zone contains a subpial stream of migratory interneurons and two in addition, that reelin controls the arrival of MGE-derived different classes of transient neurons, the pioneer neurons pro- interneurons to the CP during early corticogenesis. vided with corticofugal axons, and the reelin-expressing Cajal– Retzius cells. We found in cultured slices that the medial ganglionic Materials and Methods eminence provides the reelin-negative pioneer neurons of the Organotypic Slices. Brains were obtained from embryos of preg- marginal zone.
    [Show full text]
  • Identity of Endogenous NMDAR Glycine Site Agonist in Amygdala Is Determined by Synaptic Activity Level
    ARTICLE Received 23 Jan 2013 | Accepted 21 Mar 2013 | Published 23 Apr 2013 DOI: 10.1038/ncomms2779 Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level Yan Li 1, Silvia Sacchi2, Loredano Pollegioni2, Alo C. Basu1, Joseph T. Coyle1 & Vadim Y. Bolshakov1 Mechanisms of N-methyl-D-aspartate receptor-dependent synaptic plasticity contribute to the acquisition and retention of conditioned fear memory. However, synaptic rules which may determine the extent of N-methyl-D-aspartate receptor activation in the amygdala, a key structure implicated in fear learning, remain unknown. Here we show that the identity of the N-methyl-D-aspartate receptor glycine site agonist at synapses in the lateral nucleus of the amygdala may depend on the level of synaptic activation. Tonic activation of N-methyl- D-aspartate receptors at synapses in the amygdala under low activity conditions is supported by ambient D-serine, whereas glycine may be released from astrocytes in response to afferent impulses. The release of glycine may decode the increases in afferent activity levels into enhanced N-methyl-D-aspartate receptor-mediated synaptic events, serving an essential function in the induction of N-methyl-D-aspartate receptor-dependent long-term potentiation in fear conditioning pathways. 1 Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, Massachusetts 02478, USA. 2 Department of Biotechnology and Molecular Sciences, University of Insubria, ‘The Protein Factory’ Research Center for Protein Biotechnologies, Politecnico di Milano and University of Insubria, Varese 21100, Italy. Correspondence and requests for materials should be addressed to V.Y.B. (email: [email protected]).
    [Show full text]
  • LP-BM5 Virus–Infected Mice Produce Activating Autoantibodies to the AMPA Receptor
    LP-BM5 virus–infected mice produce activating autoantibodies to the AMPA receptor Elena Koustova, … , Michael A. Rogawski, Anthony S. Basile J Clin Invest. 2001;107(6):737-744. https://doi.org/10.1172/JCI11500. Article Autoantibodies to α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors may contribute to chronic hyperexcitability syndromes and neurodegeneration, but their origin is unclear. We examined LP-BM5 murine leukemia virus–infected mice, which manifest excitotoxic brain lesions and hypergammaglobulinemia, for the presence of AMPA- receptor Ab’s. Endogenous IgG accumulated upon neurons in the neocortex and caudate/putamen of infected mice and interacted with native and recombinant AMPA-receptor subunits with the following relative abundance: GluR3 ≥ GluR1 > GluR2 = GluR4, as determined by immunoprecipitation. In a radioligand assay, IgG preparations from infected mice specifically inhibited [3H]AMPA binding to receptors in brain homogenates, an activity that was lost after preadsorbing the IgG preparation to immobilized LP-BM5 virus. These IgGs also evoked currents when applied to hippocampal pyramidal neurons or to damaged cerebellar granule neurons. These currents could be blocked using any of several AMPA receptor antagonists. Thus, anti–AMPA-receptor Ab’s can be produced as the result of a virus infection, in part through molecular mimicry. These Ab’s may alter neuronal signaling and contribute to the neurodegeneration observed in these mice, actions that may be curtailed by the use of AMPA-receptor antagonists. Find the latest version: https://jci.me/11500/pdf LP-BM5 virus–infected mice produce activating autoantibodies to the AMPA receptor Elena Koustova,1 Yoshitatsu Sei,2 Linda Fossom,1 Mei-Ling Wei,3 Peter N.R.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]